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Investigation of cartilage degradation in patients with spinal
cord injury by CTX-II
G Findikoglu1, B Gunduz2, H Uzun1, B Erhan2, S Rota3 and F Ardic1
Study design: Clinical cross-sectional study.
Objectives: To investigate the cartilage degradation by turnover of C-telopeptide fragments of collagen type-II (CTX-II), a molecule
specific for articular cartilage in spinal cord injured patients with respect to clinical functional status.
Setting: Physical Medicine and Rehabilitation Clinics, hospital settings.
Methods: In 68 patients with spinal cord injury (SCI) level and severity of lesion, duration of disease, American Spinal Injury
Association Impairment Scale (AIS), motor and sensory score, presence of spasticity, functional ambulation score (FAS) and duration of
daily ambulation were evaluated. Cartilage degradation was demonstrated by urinary CTX-II (uCTX-II) measured by enzyme-linked
immunosorbent assay. T test, analysis of variance and Pearson correlation analysis were used for statistical calculations.
Results: uCTX-II level was significantly higher in patients with AIS grade A, non-functional ambulators or in patients who did not
ambulate at all (Po0.05). Although AIS grade, lower extremity motor score, FAS score and duration of daily ambulation were found to
be correlated (Po0.05) with uCTX-II, duration of disease, level of neurological lesion, presence of spasticity were not.
Conclusion: This is the first study providing evidence that cartilage degradation is associated with elevated uCTX-II levels in non-
ambulating or non-functional ambulating SCI patients. AIS grade A, FAS zero score and no time for daily ambulation were found to
cause significant differences in CTX-II level. It may be important to initiate therapeutic programs as soon as possible after SCI to
prevent cartilage atrophy.
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INTRODUCTION
In the patients with spinal cord injury (SCI), neurological severity
depending on the level and the extent of the injury determines the
functional status of the extremities, which may remain partially or
totally unloaded and restricted in movement. Most of the literature
studying the effect of unloading or immobilization on articular
cartilage is animal studies, which demonstrate morphologic, biochem-
ical and biomechanical adaptations.1
Mechanical loading is known to influence the development, main-
tenance and aging of skeletal tissues including articular cartilage.
External stimulus is supposed to effect cell differentiation.1 It has
been proposed that intermittent hydrostatic pressure promotes carti-
lage biosynthesis and maintains its structural and functional compe-
tence, and that shear stress, prolonged static loading or absence of
loading promote cartilage degradation and ossification.2
Joint unweighting is proposed to promote tidemark advancement
and thinning of the uncalcified cartilage layer.1 Decrease in sound
speed by scanning acoustic microscopy was observed in the transi-
tional area, indicating the softening of the articular cartilage as early as
1 week after immobilization in rats.3 A decrease in canine tibial
cartilage thickness after rigid immobilization was observed in contrast
with the findings after non-rigid immobilization.4 Enneking and
Horowitz5 found normal cartilage in human knee joints with SCI of
3 and 1.5 years of duration.
Research on effect of immobilization on articular cartilage in
human relies on non-invasive radiological studies. Narrowing of the
hip joint space by 450% in patients with flaccid paralysis was
identified by radiography. However, radiography does not allow direct
visualization of cartilage. Significant differences in patellar and tibial
cartilage thickness of SCI patients compared with healthy volunteers
were shown by magnetic resonance imaging (MRI).4,6 Furthermore, a
longitudinal MRI study showed progressive loss of thickness 12 and 24
months after SCI in patellar, tibial cartilage compared with thickness
in 6 months and of healthy controls.6 Local areas of thinning was
shown for the cartilage of the patella 6 and 12 months after injury by
thickness maps and morphological parameters.7
Progressive loss of articular cartilage is the hallmark of osteoarthritis
(OA). Change in joint space width detected by radiography is the gold
standard. On the other hand, it does not allow the early detection of
cartilage damage or the efficient monitorization of treatment due to its
poor sensitivity and relatively large precision error.8 Biochemical
markers that reflect variations in joint tissue remodeling have been
proposed as a tool for early detection of cartilage damage. Analysis of
body fluids can provide information regarding the turnover of the
cartilage before the development of gross pathology and can help to
follow changes attributable to the treatment.9
Type II collagen is cartilage specific and forms the basic fibrillary
structure of the extracellular matrix of hyaline cartilage, which is
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broken down by matrix metalloproteinases. The degradation of
mature matrix type II collagen can be assessed by measuring the
urinary excretion of crosslinked C-telopeptide fragments (uCTX-II)
by monoclonal antibodies. Concentrations of uCTX-II were found to
be higher in patients with OA or rheumatoid arthritis.9 In patients
with OA, CTX-II is associated with the burden of the disease within
one or multiple joints and higher levels are associated with more rapid
radiological progression.8
In tail suspended rats, it was demonstrated that skeletal unloading
increased systemic type-II collagen degradation that correlated signifi-
cantly with tidemark advancement and increased the alkaline phospha-
tase expression at the deep zone.10 However, to our knowledge, there is
no report on the effects of unloading on turnover of type II collagen in
SCI patients, as well as on functional status of the patients related with
level of injury, severity of injury, duration of disease, type and duration
of ambulation, and spasticity of joints. Therefore, we aimed to demon-
strate cartilage degradation associated with biochemical changes mea-
sured by uCTX-II in SCI patients with respect to functional status for
the first time and explain the relationship between joint use or disuse
and cartilage adaptation as a critical step in the process of developing
strategies to prevent and treat cartilage disorders in SCI patients.
MATERIALS AND METHODS
A total of 68 SCI patients (20 women and 48 men) between 20–79 years of age
who were followed in the Physical Medicine and Rehabilitation Clinics
departments of two centers between March and June 2010 and fulfilled the
inclusion-exclusion criteria were included in the study (Table 1).
Patients were examined according to the International Standards for
Neurologic Classification of Spinal Cord Injury by doctors of medicine in
Physical Medicine and Rehabilitation. All patients were evaluated for duration
of disease, level and severity of neurological lesion, duration of daily ambula-
tion, and upper and lower extremity motor and sensory score by the American
Spinal Injury Association (ASIA) Impairment Scale (AIS),11 presence of
spasticity by Ashworth Scale12 and ambulatory status by functional ambulation
score (FAS).13 None of the patients were taking a physical exercise program at
the time of the study. Functional status of patients was evaluated as ‘able to do’,
‘able to do with assistance’, or ‘not able to do’.
Second void morning urine samples after an overnight fasting were collected
to avoid a possible diurnal variability of the CTX-II and kept at 20 1C until
analyzed. If patients were using a clean intermittent catheter, second sample of
urine was taken. CTX-II was measured in the same lab using a competitive
enzyme-linked immunosorbent assay (CartiLaps; IDS, Boldon, UK) based on a
mouse monoclonal antibody raised against the EKGPDP sequence of human
type II collagen C-telopeptide according to the manufacturer’s instructions.
The uCTX-II level (mg l1) was corrected by the urinary creatinine concentra-
tion (CTX-II ng per creatinine mmol). Creatinine measurement was performed
by Architect ci8200 (Abbott Laboratories, Abbott Park, IL, USA) analyzer.
This study was planned as a cross-sectional clinical study of two centers. The
research protocol was approved by the Ethical committee. We certify that all
applicable institutional and governmental regulations concerning the ethical
use of human volunteers were followed during the course of this research.
As uCTX-II values were not normally distributed, a logarithmic transforma-
tion was applied (log uCTX-II). T test and analysis of variance were used for
comparison of groups. Pearson correlation analysis and linear regression were
used to find the relation between the factors under investigation. Po0.05 was
accepted as significant. SPSS 17.0 program (SPSS Inc., Chicago, IL, USA) was
used for statistical calculations.
RESULTS
In all, 20 (24. 9%) female and 48 (70.6%) male SCI patients with a
mean age of 39.88±14.01 years and a mean body mass index of
24.12±5.13 kgm2 were included in the study (Table 2). Range of
duration of disease was between 4–64 months (mean: 62.49±62.66
months). A total of 20 patients (24.9%) were tetraplegic and 48
(70.6%) were paraplegic. Mean ASIA total motor score was
53.48±28.33. Mean motor score of lower and upper extremities
were 7.61±12.81 and 45.87±25.60, respectively. In all, 36 (52.9%)
patients had spasticity (Table 2). Functional and ambulatory status of
patients evaluated by FAS are shown in Table 3. Average duration of
daily ambulation on the condition that joints were loaded was found
to be 100.92±123.27min.
As level of log uCTX-II was not found to be correlated with factors
that were supposed to effect level of CTX-II such as age, gender,
weight and body mass index, a correction was not applied.
Level of log uCTX-II was not significantly different among AIS
grades and between males and females (Table 4). As distribution of
number of patients in each AIS grade, in each FAS score group and in
Table 1 Inclusion exclusion criteria for admission
Inclusion criteria
Patients with SCI for at least 3 months
Postmenopausal, if women
Exclusion criteria
Taking drugs for osteoporosis (estrogens, bisphosphonates, selective estrogen
receptor modulators)
Taking drugs interfering with bone metabolism (prednisolone, anabolic androgens,
teriparatide)
Having metabolic disorder of bone (hyperthyroidism, hyperparathyroidism)




Intra-articular steroid or hyaluronic acid injection within last 3 months
Abbreviation: SCI, spinal cord injury.
Table 2 Demographic characteristics and neurological findings of
the patients
Age (years) 39.88±14.01
Gender (female/male) n 20/48
BMI (kgm2) 24.12±5.13











ASIA total motor score 53.48±28.33
ASIA upper extremity motor score 45.87±25.60
ASIA lower extremity motor score 7.61±12.81
ASIA total pin prick score 56.94±26.07
ASIA total light touch score 62.13±26.57
Presence of spasticity 36 (52.9%)
Abbreviations: AIS, American Spinal Injury Association Impairment Scale; ASIA, American
Spinal Injury Association; BMI, body mass index.
Values are represented as mean±s.d. or n (%).
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groups of daily ambulation time were low in number for comparison,
patients were grouped as AIS grade A and others (non-A), FAS score
zero and others (non-zero) and patients who did not ambulate vs
patients who spend time for daily ambulation. Log uCTX-II level was
found to be significantly different in grade A patients than non-A
patients (Po0.05) and patients with FAS zero score than others (non-
zero; Po0.05). Patients who did not spend time for daily ambulation
had a significantly higher log uCTX-II level compared with ambulat-
ing patients. This finding was supported by the answer to a simple
question asked to the patient: ‘Can you walk?’ Patients who described
themselves to walk had significantly lower log uCTX-II level than
patients who did not (Po0.05). Patients with and without spasticity
in the joints did not have statistical difference in levels of log uCTX-II
(P40.05).
Duration of disease, level of neurological lesion, ASIA total or upper
extremity motor score and presence of spasticity were not correlated
with CTX-II level (P40.05; Table 5). On the other hand, AIS grade,
FAS score, duration of daily ambulation and ASIA lower extremity
motor score were found to be correlated with level of log uCTX-II.
FAS score was also correlated with level of injury (r¼0.377, Po0.05).
Among these factors, FAS score was found as the most effective
determinant on CTX-II level by regression analysis.
DISCUSSION
Experimental evidence indicated that the biosynthetic response of
chondrocytes was sensitive to the frequency and amplitude of loading.
Excessive, repetitive loading may induce cell death, and cause mor-
phological and cellular damage as seen in degenerative joint disease. It
was demonstrated that continuous cyclic hydrostatic pressure (5MPa,
1Hz for 4 h) induced apoptosis in human chondrocytes derived from
osteoarthritic cartilage in vitro. In contrast, cyclic, physiological-like
loading was found to trigger a partial recovery of morphological and
ultrastructural aspects in osteoarthritic human articular chondro-
cytes.8 Although overloading or continuous loading have severe effects
on the cartilage, it is interesting to note that unloading or restricted
movement appear to cause degenerative changes.
It was shown that cartilage formation was induced by intermittent
compression and tension administered to chick embryonic tissue.
However, immobilization of the cell cultures caused transformation of
this cartilage into a bone-like structure. This finding implies that once
developed, cartilage tissue requires mechanical stimulation to be
maintained as cartilage and not undergo endochondral ossification.14
Decreased stiffness of articular cartilage was shown after a period of
joint immobilization based on the instantaneous shear modulus and
equilibrium shear modules of canine cartilage. A decrease in sound
speed in the transitional area of both the femoral and tibial cartilage,
indicating the softening of cartilage as early as 1 week after immobi-
lization in rat knee was observed.3 In an experimental study of Tomiya
et al., it was demonstrated that skeletal unloading temporarily
accelerated subchondral ossification and induced a full-thickness
patellar cartilage defect without any fibrillation, and alkaline phos-
phatase activity was increased at the deep zone in hindlimb-suspended
rats. In addition, a significant correlation between the uCTX-II levels
and tidemark advancement was observed.10
Type II collagen is localized almost exclusively in articular cartilage,
where it is a major structural component of the tissue. Hence,
Table 3 Functional status, functional ambulatory status of patients
and duration of ambulation
Able to do,
n (%)
Able to do with
assistance, n (%)
Not able to do,
n (%)
Functional status
Turning in bed 51 (14.7) 7 (10.3) 10 (14.7)
Sitting after lying in bed 48 (70.6) 5 (7.4) 15 (22.1)
Sitting (knee bended) 48 (70.6) 8 (11.8) 12 (17.6)
Sitting (knee extended) 41 (60.3) 10 (14.7) 17 (25)
Standing from sitting position 28 (41.2) 17 (25) 23 (33.8)
Maintain standing balance 20 (29.4) 18 (26.4) 30 (44.1)
Walking 17 (25) 9 (13.2) 42 (61.8)
Climbing stairs 8 (11.8) 6 (8.8) 54 (79.4)
Functional ambulation
Non-functional ambulator (score 0) 49 (72.1)
Ambulator-dependent for physical assistance-level 2 (score 1) 2 (2.9)
Ambulator-dependent for physical assistance-level 1 (score 2) 4 (5.9)
Ambulator-dependent for supervision (score 3) 1 (1.5)
Ambulator-independent-level surfaces only (score 4) 6 (8.8)
Ambulator-independent (score 5) 6 (8.8)
Duration of ambulation/day, mean (range) 102.92±123.27
(0–720)
Table 4 Comparison of characteristics of SCI patients with respect to
log CTX-II level




Female (n¼20) 2.84±0.35 40.05
Male (n¼48) 2.76±0.36
Level of injury





A (n¼37) 2.85±0.34 o0.05
Non-A (B, C, D) (n¼31) 2.63±0.35
FAS
Non-functional ambulator (score 0;
n¼49)
2.85±0.33 o0.05
Non-zero (score 1, 2, 3, 4, 5; n¼19) 2.60±0.35
Duration of ambulation
0min (n¼21) 2.92±0.34 o0.05
40min (n¼47) 2.72±0.35
Walking
Able to do (n¼17) 2.58±0.36 o0.05
Not able to do (n¼42) 2.85±0.32
Presence of spasticity
No (n¼32) 2.85±0.35 40.05
Yes (n¼36) 2.72±0.36
Abbreviations: AIS, American Spinal Injury Association Impairment Scale; FAS, functional
ambulation score; SCI, spinal cord injury; uCTX-II, urinary collagen type-II.
Statistically significant values are shown in bold (t test, analysis of variance).
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measurements of fragments derived from this protein may potentially
be a specific marker for cartilage degradation.9
Our results support the findings of the other reports related with
the effects of immobilization. Patients with a complete lesion of
the spinal cord, or who were non-ambulators or non-functional
ambulators were found to have a higher risk of cartilage degradation.
It might be expected that as the level of injury gets higher, uCTX-II
level is more elevated. In contrast, we did not find any correlation
between uCTX-II and level of injury or any difference among groups
of injury levels. As the FAS score is found to be correlated with the
level of injury, this finding might be partially because of the distri-
bution of small number of patients in injury groups. On the other
hand, severity of injury is another factor determining the functions
of extremities. We demonstrated that patients with complete lesion
had higher uCTX-II levels. Partially preserved muscle function could
allow better mobilization of joints and thus better ambulation.
Spasticity was not found to be effective on level of CTX-II, indicating
that muscular contractions might not provide sufficient loading for
articular cartilage.
Vanwanseele et al.,6 showed a progressive thinning in knee cartilage
of SCI patients by MRI. Decrease in mean cartilage thickness in 12
months varied between 9–13% in the four compartments of tibio-
femoral joint and the patella. Follow-up of SCI patients 12 and 24
months after injury demonstrated 14–16% and 19–25% of reduction
in patellar and tibial cartilage thickness, respectively, compared with
data in 6 months.4 Additionally, in 43% of the patients, the individual
thickness maps and morphological parameters revealed local areas of
atrophy in patellar cartilage 6 and 12 months after injury.7 In contrast
to these, we did not find any correlation between duration of disease
and level of uCTX-II. Since cases we included were heterogenous in
terms of duration of disease, which might have affected uCTX-II level.
This finding might further imply that ambulatory status could be
more important than the duration of disease in degradation of
articular cartilage.
Level of uCTX-II usually reflects systemic disorders, as opposed to
a single joint disorder. uCTX-II implied the involvement of multiple
joints in our patients who were expected not to be able to use or to
disuse the joints below the level of the lesion. The presence of inter-
vertebral disk disease or degenerative involvement of the non-paralytic
joints may seem as a confounding factor.15,16 In a study on cartilage
of shoulder joints that take part in ambulation and transfers of
complete paraplegic patients, no significant changes was observed in
MRI findings.7
Although we did not provide any radiographical evidence for
the degenerative findings, an association between uCTX-II and the
severity, prevalence and the progression of radiographic OA at the
knee and hip was observed.1,16–18 Imaging modalities yield results only
when gross damage to the cartilage has already occurred.9 On the
other hand, one must consider the difficulties of optimal positioning
of the patients with paralysis, which requires loading in flexed
position. Furthermore, uCTX-II was shown to have a relatively strong
association with longitudinal loss of cartilage shown by MRI, which is
more sensitive than radiography in detecting cartilage loss.19,20
One of the limitations of our study is the relatively small number of
patients. In addition, as this study was designed as a cross-sectional
study, it does not reflect alterations in cartilage over the time.
Radiological demonstration of cartilage thinning would be considered
for the further support of biochemical findings.
The findings of our study have some clinical implications. If patients
are immobilized for substantial periods of time, stress distribution
may change and degradation of the cartilage may occur that predis-
pose the joint to osteoarthritic degeneration. Therefore, it may be
important to initiate therapeutic programs as soon as possible after
SCI. This is particularly important, as some animal studies indicated
that changes in the cartilage during immobilization were not fully
reversible after remobilization.4 The extent to which the changes
can be decelerated or prevented by therapeutic interventions is also
not known. It needs to be determined further weather CTX-II could
monitor the effectiveness of exercise programs.
CONCLUSION
As a conclusion, non-ambulatory or non-functional ambulatory SCI
patients or patients with complete injury of spinal cord were found to
be associated with increased level of a cartilage-specific biological
marker, CTX-II. Duration of disease, AIS A grade, FAS zero score
and daily ambulation time might cause significant differences in
the level of CTX-II. It could be proposed that this increase might
reflect degradation of cartilage and, thus, development of degenerative
diseases due to the unloading or abnormal stress distribution. It may
be important to initiate therapeutic programs as soon as possible after
SCI to prevent cartilage degradation.
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